OSU K12 Training Grant in Oncology

OSU K12 肿瘤学培训补助金

基本信息

批准号：
10477991
负责人：
WILLIAM E. CARSON
金额：
$ 81万
依托单位：
OHIO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-09-09 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10477991
关键词：
Applied Research Area Basic Science Clinical Clinical Investigator Clinical Research Clinical Trials Comprehensive Cancer Center Discipline Doctor of Philosophy Ensure Faculty Financial Support Goals Grant Hematology Individual Investigation Investigational Therapies Laboratories Malignant Neoplasms Medical Oncology Medicine Mentored Clinical Scientist Development Program Mentors Minority Groups Ohio Oncology Paper Peer Review Program Evaluation Radiation Oncology Research Research Personnel Resources SECTM1 gene Structure Surgical Oncology Training Training Programs Underserved Population Universities Women&apos s Group anticancer research base cancer diagnosis cancer prevention career career development drug development education research effectiveness evaluation interest laboratory development programs recruit success survivorship translational cancer research translational scientist

项目摘要

Project Summary/Abstract The goal of this proposal is to mentor and train junior faculty investigators in laboratory and/or clinical translational cancer research. Implementation of this K12 program for the career development of laboratory-based (PhD/DVM/MD) and clinical (MD or MD/PhD) translational scientists in diverse areas of oncology will ensure a cadre of highly-trained individuals who can communicate across disciplines to drive new advancements in how we approach cancer diagnosis and management. This K12 program from The Ohio State University Comprehensive Cancer Center (OSUCCC) continues its focus on early drug development, but now also extends to cancer prevention, control and survivorship research. The OSUCCC is clearly dedicated to research education and providing outstanding career development and mentoring opportunities to promising junior faculty. The Divisions of Hematology, Medical Oncology, Radiation Oncology, and Surgical Oncology each have robust programs that are continuously recruiting new junior faculty to facilitate expansion of our cancer program. Recruitment efforts also emphasize the inclusion of women, minorities and underserved groups to increase diversity. This K12 grant fills an important need by extending research education, career development and mentoring to junior faculty interested in establishing academic research careers. It is the only OSUCCC training program dedicated solely to faculty-level career development in cancer research, and thus has no overlap with any of the OSU T32 training grants, which focus on fellows. This strategy ensures continuity in training and provides individuals a structured path to become independent clinical or translational investigators. The quality of this K12 program and its success in training cancer researchers is exemplified by the career trajectories of past trainees, their papers, grants, clinical trials and other scholarly activities that have driven new discoveries. The continued success of this program will be ensured by the overall strength and direction of the OSUCCC, as demonstrated by its recent peer review score of 10 (exceptional), financial support of this K12 program by the OSUCCC and by different Divisions and Departments, and the enormous breadth of expertise and resources available at OSU. This K12 program seeks to train two types of investigators. The first includes MD and/or PhD faculty who have outstanding basic science training and want to pursue laboratory-based investigation related to applied research in experimental therapeutics, cancer prevention, control, and survivorship. The second group includes MD or MD/PhD faculty who want to pursue clinical research in experimental therapeutics and cancer prevention, control, or survivorship. Training plans are tailored to each individual trainee to facilitate their success, with inclusion of a robust evaluation program to assess the effectiveness of the K12. The value of the OSU K12 program is best demonstrated by nearly all of the current and past K12 scholars remaining in academic medicine and moving forward as independent laboratory or clinical investigators.

项目概要/摘要该提案的目标是指导和培训实验室和/或临床转化方面的初级教师研究人员癌症研究。实施该 K12 计划以促进基于实验室的职业发展肿瘤学不同领域的（博士/DVM/医学博士）和临床（医学博士或医学博士/博士）转化科学家将确保一支由训练有素的人员组成的骨干队伍，他们可以进行跨学科交流，以推动新的进步我们致力于癌症诊断和管理。俄亥俄州立大学的 K12 课程综合癌症中心 (OSUCCC) 继续关注早期药物开发，但现在还扩展了癌症预防、控制和生存研究。 OSUCCC 明确致力于研究教育为有前途的初级教师提供出色的职业发展和指导机会。这血液学、肿瘤内科、放射肿瘤学和肿瘤外科各科室均拥有强大的不断招募新的初级教师以促进我们的癌症项目扩展的项目。招聘工作还强调纳入妇女、少数族裔和服务不足的群体，以增加多样性。这项 K12 赠款通过扩展研究教育、职业发展和指导有兴趣建立学术研究职业的初级教师。这是唯一的 OSUCCC 培训该计划仅致力于癌症研究中教师级别的职业发展，因此与任何 OSU T32 培训补助金，主要针对研究员。该策略确保了培训的连续性和为个人提供成为独立临床或转化研究人员的结构化途径。品质该 K12 项目的成功及其在培训癌症研究人员方面的成功可以从以下人员的职业轨迹中得到例证：过去的学员、他们的论文、资助、临床试验和其他推动新发现的学术活动。 OSUCCC 的整体实力和方向将确保该计划的持续成功，因为最近的同行评审得分为 10 分（优异），证明了该 K12 项目的财政支持 OSUCCC 以及不同的部门和部门，以及广泛的专业知识和资源可在俄勒冈州立大学获得。该 K12 计划旨在培训两种类型的调查员。第一个包括医学博士和/或博士学位受过杰出基础科学训练并希望从事与实验室研究相关的教师实验治疗、癌症预防、控制和生存方面的应用研究。第二组包括想要从事实验疗法和癌症临床研究的医学博士或医学博士/博士教师预防、控制或生存。培训计划是针对每个学员量身定制的，以促进他们的成功，包括一个强大的评估计划来评估 K12 的有效性。的价值几乎所有当前和过去的 K12 学者仍然从事学术工作，OSU K12 项目得到了最好的证明。医学并作为独立实验室或临床研究人员向前发展。